117results about How to "Extended incubation period" patented technology

The invention provides a single-component high / low-temperature-resistant epoxy resin composition which comprises the following ingredients in parts by weight: 100 parts of rubber cross-linked modified epoxy resin, 0-20 parts of cardanol-type glycidol ether, 80-120 parts of alicyclic acid anhydride curing agent, 0.5-10 parts of latent curing accelerator, 10-40 parts of polyacrylate core-shell compound particle toughener, 2-20 parts of thixotropic agent and 50-100 parts of filler. The epoxy resin composition has the advantages of high toughness, high / low-temperature alternation resistance, simple preparation technique, low viscosity and favorable flowability, and can greatly enhance the packaging reliability and durability of electronic devices.

The present invention provides a helicid powder injection and its preparation method. Every powder injection contains 25-600 mg of helicid, and the rest is medicinal auxiliary material for injection. It has good stability, can be stored for 3 years at normal temperature, its irritation is small, and its injection site has no clear change or light hyperemia, and its sedation effect is good, and its convulsion-resisting action is strong, it can obviously reduce coriamyrtin convulsion incidence rate, prolong generative latent period, reduce frequency of attack and shorten time and process of attack. The tests show that said helicid powder injection has the strong action of stopping pain and relieving inflammation.

A helicidium softcapsule is composed of the liquid medicine and shell material, and features that said dliquid medicine is prepared from superfine helicidum particles and medicinal auxiliary.

The invention discloses 2-hydroxychalcone amine compounds and pharmaceutically-acceptable salts, preparation method thereof, pharmaceutical composition, and uses for preparing medicines treating and / or preventing neurodegenerative related diseases, the diseases including but not limited to vascular dementia, Alzheimer's disease, Parkinson's disease, Huntingdon's disease, HIV associated dementia, multiple sclerosis, progressive lateral sclerosis, neuropathic pain, glaucoma and other neurodegenerative diseases.

The invention discloses a novel carbamate chalcone compound represented by a formula I shown in the description and pharmaceutically acceptable salts thereof, a preparation method for the novel carbamate chalcone compound and the pharmaceutically acceptable salts thereof, a pharmaceutical composition and use of the pharmaceutical composition in the preparation of drugs for treating and / or preventing neurodegenerative related diseases, including, but not limited to neurodegenerative diseases such as vascular dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, HIV related cretinism, multiple sclerosis, progressive lateral spinal sclerosis, neuropathic pain and glaucoma.

Disclosed is a compound Chinese medicinal preparation for treating asthma, which is prepared from the following raw materials, gingko, Chinese ephedra, purple perilla seed, licorice root, coltsfoot flower, bitter apricot seed, mulberry bark, baikal skullcap root and pinellia tuber.

The invention discloses a tuckahoe extract which is prepared through ethanol extraction and macroporous absorption resin purification. The tuckahoe extract enriches more effective parts. Moreover, a rat memory disorder model test proves that the tuckahoe extract can improve the learning and memory capacity of a model rat, so that the number of errors of the model rat is reduced and the latent period is prolonged.

A Chinese medicine for treating senile dementia, dizziness, disturbed sleep, etc is prepared from fleece flower root, lotus leaf, cistanche, earthworm and uniflower swisscentaury root through respective extracting, and proportional mixing.

The present invention relates to a kind of medicine composition for treating productive cough, and the medicine composition has ambroxol hydrochloride, guaifenesin and levosalbutamol in certain weight proportion and pharmaceutically acceptable supplementary material. The medicine composition may be prepared into pharmaceutically acceptable preparation forms for treating productive cough caused by chronic bronchitis, asthma, repeatable lower respiratory infection and other respiratory system diseases.

A Chinese medicine in the form of capsule, stable, particle, or oral liquid for treating pulmonary heart disease is prepared from 3 Chinese medicinal materials including astragalus root, red peony root and psoralea fruit through decocting twice (each time for 1 hr.), filtering, concentrating up to relative density of 1.05-1.15 at 80 deg.C, depositing in alcohol standing still for 24 hr, recovering alcohol, continuously concentrating up to relative density of 1.35-1.40 at 80 deg.C concentrating, mixing with red peony root powder, stirring, drying, pulverizing and granulating.

An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the prescribed time. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent and a nutrient. In the preferred form, the medicine comprises: Echinacea and Commiphora myrrha phytochemicals, benzalkonium chloride, a sterile water solution, and folic acid.

The present invention discloses a Chinese medicine for curing common cold, which is made up by using 6 Chinese medicinal materials of forsythia fruit, lonicera flower, sweet wormwood, bupleurum root, bitter apricot kernel and platycodon root as raw material through the a certain preparation process. Said medicine has the functions of clearing away heat and toxic material, resisting virus, resisting bacteria, resisting inflammation and relieving cough, and is suitable for curing wind-heat type common cold.

A Chinese medicine for treating cold is proportionally prepared from bupleurum root, scutellaria root, pueria root and liquorice root. Its preparing process and its quality control method are also disclosed.

The invention provides a dripping pill preparation for removing phlegm and relieving cough, which mainly comprises root of ballon flower, caffeine, polygala root, boneol, bitter apricot seed, Chinese gall and licorice root. The invention also provides the process for preparing the dripping pill preparation.

The invention relates to a medicine compound from Chinese traditional medicines and its manufacturing method, the utilization of the medicine and its ingredients. The medicine is applied to cure spirit and nerve system diseases, such as anxiety neurosis and depressions.

Provided is a method for identifying the level of fetal risk during labor comprises monitoring at least each of the concurrent clinical parameters of (a) FHR, (b) baseline FHR variability, (c) FHR accelerations, (d) FHR decelerations, and (e) maternal uterine activity, to determine whether each parameter independently exhibits at least one non- reassuring characteristic, and indicating a present level of risk to the fetus corresponding to the number of the concurrent clinical parameters (a) through (e) that are simultaneously, independently non-reassuring. An apparatus for implementing the method comprises at least one computer operative to receive input signals indicative of at least FHR and maternal uterine activity in a patient. The computer is operative to determine from the FHR baseline FHR variability, FHR accelerations, and FHR decelerations, to determine when any one or more of the parameters (a) through (e) each exhibit at least one non-reassuring characteristic, and to determine a present level of risk to the fetus corresponding to the number of the parameters (a) through (e) that are simultaneously, independently non-reassuring. At least one output operatively connected to the at least one computer indicates the determined present level of risk to the fetus.

The invention relates to an application of levetiracetam injection in preparation of nootropic drugs. At present, levetiracetam is an antiepileptic drug with a very good curative effect, and researches find that the drug has a better curative effect in the nootropic aspect. The invention aims to further explore the application of the levetiracetam injection in the nootropic aspect, which has the advantages of quick drug effect, strong practicability and storability, compared with oral preparations.

The invention relates to a cyanate ester resin latent catalyst and a preparation method thereof, and belongs to the technical field of preparation of catalytic cyanate ester resin and a composite material thereof. According to the cyanate ester resin latent catalyst prepared by adopting a microcapsule technology, when the prepreg needs to be cured,microcapsules are broken after proper pressure ortemperature is applied on the prepreg, and a curing agent enters a matrix, so that the purpose of catalyzing the curing of a cyanate ester resin is achieved. In addition, the latent catalyst / cyanate ester resin prepreg disclosed by the invention also has better paving manufacturability and is beneficial to forming of the cyanate ester resin-based composite material. The application range of the cyanate ester resin-based related material is widened, and the application prospect is wide. The latent catalyst and the cyanate ester resin prepreg can be used for preparing a skin for a wave-transparent structure integrated part, meet the requirement of an antenna radome and other parts for high wave-transparent rate, can also be used as a copper-clad plate base material, and can be widely appliedto the fields of electronics, aviation and aerospace.

A Chinese medicine for treating cough and asthma is prepared from 4 Chinese-medicinal materials including scutellaria root, platycodon root, phabitis seed, etc. Its advantages are high curative effect, no toxic by-effect and low cost.

The medicine for treating chronic bronchitis is compound medicine comprising fermented aweto powder, Sichuan fritillary bulb and loquat leaf with the functions of invigorating lung and kidney, benefiting vital energy, nourishing Yin, clearing away heat, eliminating phlegm, and relieving cough and asthma. It may be prepared into any pharmaceutically acceptable orally taken preparation forms. The medicine, pharmacodynamics test shows, has the functions of relieving cough, eliminating phlegm, resisting anoxia, resisting fatigue, resisting cold, diminishing inflammation and raising immunity, and has total effective rate on chronic bronchitis of 90.59 %,

The invention discloses a Chinese herbal compound volatile oil part for treating asthma and a preparation method thereof. The Chinese herbal compound volatile oil part is extracted by steam distillation from a crude drug which is made from licorice, Chinese ephedra, bitter apricot kernel, pinellia tuber, gypsum, tea bust and Chinese magnolivine fruit according to certain weight proportion by parts with the yield of 0.17%. The Chinese herbal compound volatile oil part has the advantages of simple preparation process, good reproducibility and low cost. Pharmacological tests prove that the Chinese herbal compound volatile oil part of the invention can obviously prolong the incubation period of asthma in animals, reduce the responsiveness of asthma airway, improve the ethological sign of asthma, obviously decrease EOS in BALF, inhibit the aggregation of main inflammatory cells EOS in lung tissues, obviously inhibit the level of inflammatory factors IL-4 and IL-5 in serum, improve the level of IFN-Gamma in serum, and regulate the balance relationship of Th1 / Th2, therefore, the Chinese herbal compound volatile oil part of the invention is ideal for preparing the medicine for treating asthma.

The invention relates to an application of compound donkey-hide gelatin pulp in preparation of medicaments for menstrual period health care, and a pharmaceutical composition for menstrual period health care, wherein the pharmaceutical composition comprises an effective amount of compound donkey-hide gelatin pulp with respect to health care, and pharmaceutically acceptable carriers. A large number of experiments find that compound donkey-hide gelatin pulp has obvious blood-enriching effect on mice with blood deficiency due to blood loss, has certain inhibition effect on contraction of rabbit uterine smooth muscle, has obvious inhibition effect on rabbit in-vivo uterine smooth muscle spasm caused by pitocin, can alleviate excess contraction of rabbit uterine smooth muscle, has obvious alleviation effect on rat dysmenorrhea response caused by pitocin, can prolong the response latency, can significantly prolong the latency of rat dysmenorrhea spasm caused by pitocin, can reduce the frequency of body torsion, has significant analgesic effect, can obviously reduce rat blood viscosity, has certain blood circulation invigorating effect, and can relieve blood property change such as viscous, thick, coagulated blood of blood-stasis model rats.

The invention provides a Chinese herbal medicine effective for wound healing, namely, loropetalum chinense leaf composition. The loropetalum chinense leaf composition contains 11 total phenolic acidsand 15 total flavonoids. Animal experiments confirm that the composition derived from loropetalum chinense leaves has a good effect on wound healing. The loropetalum chinense leaves are planted and managed standardly in Jiangxi, and the source of the medicinal material is guaranteed. According to the loropetalum chinense composition, an extraction method is simple, operation is easy, and application range is wide. A basis for further medicinal development of the loropetalum chinense leaves is provided.

The invention provides new application of green tea polyphenol in preventing and treating psychological stress injuries, which further shows that the green tea polyphenol has application in preparing medicaments or foods for preventing and treating symptoms or diseases correlative with the psychological stress injuries. The green tea polyphenol can improve the prolongation of latency and the reduction of grill-passing times and erection times of a Wistar rat in an open field test in a psychological stress state; the latency is prolonged and the number of electric shocks is increased in a step-through test; and the performance that the time for finishing a water maze and the number of errors are obviously increased is abnormal, which shows that the green tea polyphenol can improve the space exploration capacity, the cognitive function and the learning and memory ability of a psychological stress animal, has the effect of preventing and treating the psychological stress injuries, and is hopeful to be used for preparing the medicaments or the foods for preventing and treating the symptoms or the diseases correlative with the psychological stress injuries.

The invention belongs to the field of traditional Chinese medicines, and relates to a traditional Chinese medicinal composition and a preparation method thereof, in particular to a traditional Chinese medicinal composition for treating gynecologic inflammation and a preparation method thereof. The technical scheme is as follows: the traditional Chinese medicinal composition comprises the following components: 10-30 parts of angelica sinensis, 8-18 parts of golden cypress, 15-25 parts of herba leonuri, 5-15 parts of dandelion, 15-20 parts of salvia miltiorrhiza, 10-20 parts of sophora flavescens, 5-15 parts of radix paeoniae rubra, 1-10 parts of folium isatidis, 5-15 parts of coptis chinensis, and 9-15 parts of fructus forsythiae. The traditional Chinese medicinal composition can achieve a good curative effect on treatment of gynecologic inflammation such as pelvic inflammation, is low in side effect, and is of an obvious clinical promotional value.

The invention relates to a method for preparing propionyl levocarnitine hydrochloride and application of medicaments thereof. The method comprises the following steps of: (1) mixing and stirring propionic acid and levocarnitine inner salt to prepare propionic acid solution of the levocarnitine inner salt, wherein a mass ratio of the propionic acid to the levocarnitine inner salt is 1:(0.5-1.5); (2) mixing and stirring the propionic acid and propionyl chloride to prepare an acylated reagent, wherein a mass ratio of the propionic acid to the propionyl chloride is 1:(1.5-10); and (3) mixing the propionic acid solution of the levocarnitine inner salt and the acylated reagent, and performing acidylation reaction to obtain the propionyl levocarnitine hydrochloride. The method is mild in condition, safe in reaction, easy to operate and low in cost, and waste gas is not generated. The medicaments which take the propionyl levocarnitine hydrochloride as active ingredients are used for treating peripheral arterial diseases and chronic congestive heart failure to enhance athletic ability, and have a good effect.

The invention discloses a pharmaceutical composition for treating irritable bowel syndrome, which consists of two raw materials of tangerine peel oil extracted from tangerine peel and clove oil extracted from clove and is mainly used for treating diarrhea type irritable bowel syndrome. The pharmaceutical composition can decrease intestinal tonicity and defecation frequency and improve feces texture and has the effects of being anti-inflammatory and antiseptic and adjusting gastrointestinal hormone and neuropeptide.